Skip to main content
Clinical Trials/CTRI/2023/10/058727
CTRI/2023/10/058727
Not yet recruiting
Phase 2

Evaluation of efficacy and safety of polyherbal unani formulation in Nazla Haar (Allergic Rhinitis) - NI

State Unani Medical College Himmatganj Prayagraj0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
State Unani Medical College Himmatganj Prayagraj
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
State Unani Medical College Himmatganj Prayagraj

Eligibility Criteria

Inclusion Criteria

  • 1\. Patient of any sex
  • 2\. Age group between 19 to 50 years
  • 3\. Patients clinically diagnosed with Nazla Haar(Allergic Rhinitis).
  • 4\. Patients with raised Total Eosinophil Count and Total Serum IgE.

Exclusion Criteria

  • 1\. Age below 19 years and above 50 years.
  • 2\. Pregnancy and Lactation.
  • 3\. Patients with history of Comorbidities like Diabetes and Hypertension, Renal impairment, etc.
  • 4\.Patients with other disease of Nose.

Outcomes

Primary Outcomes

Not specified

Similar Trials